Micropapillary Predominant Lung Adenocarcinoma in Stage IA Benefits from Adjuvant Chemotherapy

ConclusionsAdjuvant chemotherapy is a favorable prognostic factor for MPP patients in stage IA but not for lung ADC patients. MPP subtype could benefit from adjuvant chemotherapy.

Source: Annals of Surgical Oncology - December 16, 2019 Category: Cancer & Oncology Source Type: research